Latest news
Radiopharm Theranostics (ASX:RAD) Advances Funding Plans with New Share Offer - Kalkine MediaKalkine Media · Fri, 07 Aug 2026 02:06:00 GMTRadiopharm Theranostics Revises SPP to Cap Maximum Issue at AUD10 Million Including AUD4 Million Oversubscriptions - Kalkine MediaKalkine Media · Wed, 05 Aug 2026 03:59:31 GMTRadiopharm Theranostics Amends SPP to Reflect Maximum Issue of AUD10 Million Including Oversubscriptions - KalkineKalkine · Wed, 05 Aug 2026 03:59:31 GMTRadiopharm (ASX:RAD) Expands Clinical Momentum with Positive Trial Updates - Kalkine MediaKalkine Media · Mon, 03 Aug 2026 09:47:00 GMTRadiopharm Theranostics Applies to Quote 408.8 Million Shares from Tranche 1 Australian Placement - KalkineKalkine · Mon, 03 Aug 2026 05:18:20 GMTRadiopharm Theranostics to Issue 848.8 Million Free Attaching Options Exercisable at $0.018 - KalkineKalkine · Thu, 30 Jul 2026 07:00:00 GMTRadiopharm Theranostics Announces 848.8 Million Free Attaching Options Exercisable at $0.018 - Kalkine MediaKalkine Media · Thu, 30 Jul 2026 07:00:00 GMTRadiopharm Theranostics Completes 384 Million Share Issue Under Corporations Act Relief - KalkineKalkine · Tue, 28 Jul 2026 07:00:00 GMT